{"id":"augment-with-memantine","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Confusion"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Memantine, a NMDA receptor antagonist, works by blocking the action of glutamate, a neurotransmitter that can be toxic to brain cells in high amounts. Augment, the other component, is not well-documented, but it may enhance the effects of memantine or provide additional benefits.","oneSentence":"Augment with Memantine is a combination of a glutamate receptor antagonist and a NMDA receptor antagonist, which may help to improve cognitive function in patients with Alzheimer's disease.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:57:35.729Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe Alzheimer's disease"}]},"trialDetails":[{"nctId":"NCT07139834","phase":"PHASE1","title":"Pattern Separation in Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Jeffrey Miller","startDate":"2026-04","conditions":"Major Depressive Disorder (MDD)","enrollment":30},{"nctId":"NCT03550391","phase":"PHASE3","title":"Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2018-11-22","conditions":"Brain Metastases","enrollment":206},{"nctId":"NCT00262470","phase":"PHASE1, PHASE2","title":"Treatment of Orthostatic Intolerance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Satish R. Raj","startDate":"1997-04","conditions":"Tachycardia, Chronic Orthostatic Intolerance","enrollment":150},{"nctId":"NCT04539951","phase":"PHASE2","title":"Pragmatic Trial of Obsessive-compulsive Disorder","status":"RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2020-09-22","conditions":"Obsessive-Compulsive Disorder","enrollment":1600},{"nctId":"NCT04789915","phase":"PHASE1","title":"Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis","status":"RECRUITING","sponsor":"Bjorn H. Ebdrup","startDate":"2021-05-26","conditions":"Psychosis, Negative Symptoms With Primary Psychotic Disorder","enrollment":46},{"nctId":"NCT06337994","phase":"PHASE3","title":"Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury","status":"COMPLETED","sponsor":"Assiut University","startDate":"2024-01-01","conditions":"Treatment of Cognitive Deficits After Traumatic Brain Injury","enrollment":60},{"nctId":"NCT05102045","phase":"NA","title":"The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2016-09-01","conditions":"Alzheimer Disease","enrollment":27},{"nctId":"NCT02258828","phase":"PHASE4","title":"An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder","status":"COMPLETED","sponsor":"Sriram Ramaswamy","startDate":"2005-07","conditions":"PTSD","enrollment":26},{"nctId":"NCT01902004","phase":"PHASE4","title":"Brain Aging and Treatment Response in Geriatric Depression","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2013-10","conditions":"Mild Cognitive Impairment (MCI), Depression","enrollment":115},{"nctId":"NCT02630888","phase":"PHASE2","title":"Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2014-08","conditions":"Bipolar Disorder","enrollment":44},{"nctId":"NCT01656187","phase":"PHASE4","title":"Attenuation of Corticosteroid Induced Hippocampal Changes","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2012-01","conditions":"Organic Memory Impairment","enrollment":46},{"nctId":"NCT00768261","phase":"PHASE4","title":"Corticolimbic Degeneration and Treatment of Dementia","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2004-11","conditions":"Dementia","enrollment":39},{"nctId":"NCT02162251","phase":"","title":"Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease","status":"COMPLETED","sponsor":"Eisai Co., Ltd.","startDate":"2013-06-01","conditions":"Alzheimer's Desease","enrollment":3482},{"nctId":"NCT00566852","phase":"PHASE3","title":"Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2008-03","conditions":"Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity","enrollment":554},{"nctId":"NCT00264238","phase":"PHASE1, PHASE2","title":"Memantine Augmentation in Obsessive-Compulsive Disorder","status":"COMPLETED","sponsor":"Stanford University","startDate":"2006-01","conditions":"Obsessive-Compulsive Disorder","enrollment":15},{"nctId":"NCT01372449","phase":"PHASE2","title":"A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)","status":"COMPLETED","sponsor":"Evdokia Anagnostou","startDate":"2011-12","conditions":"Autism Spectrum Disorder","enrollment":23},{"nctId":"NCT01392287","phase":"PHASE1","title":"Treatment Resistant Geriatric Depression in Primary Care","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2010-05","conditions":"Major Depressive Disorder","enrollment":12},{"nctId":"NCT00462228","phase":"PHASE4","title":"Effect of Namenda on Short Term Memory and Attention in Patients With Mild to Moderate Traumatic Brain Injury","status":"TERMINATED","sponsor":"University of Missouri-Columbia","startDate":"2007-04","conditions":"Traumatic Brain Injury","enrollment":11},{"nctId":"NCT01876823","phase":"PHASE2, PHASE3","title":"Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2006-04","conditions":"Mild Cognitive Impairment, Major Depressive Disorder, Alzheimer's Disease","enrollment":60},{"nctId":"NCT01533493","phase":"NA","title":"Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2012-05","conditions":"Attention Deficit Hyperactivity Disorder (ADHD), Executive Function Deficits (EFD)","enrollment":33},{"nctId":"NCT00585169","phase":"PHASE2","title":"Memantine Treatment Study of Pathological Gambling","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-12","conditions":"Pathological Gambling","enrollment":29},{"nctId":"NCT01025466","phase":"PHASE4","title":"Exelon Patch and Combination With Memantine Comparative Trial","status":"COMPLETED","sponsor":"Inha University Hospital","startDate":"2008-12","conditions":"Alzheimer's Disease","enrollment":206}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":117,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Augment with Memantine","genericName":"Augment with Memantine","companyName":"Shanghai Mental Health Center","companyId":"shanghai-mental-health-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Augment with Memantine is a combination of a glutamate receptor antagonist and a NMDA receptor antagonist, which may help to improve cognitive function in patients with Alzheimer's disease. Used for Moderate to severe Alzheimer's disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}